Nonprescription Drugs
Considering a New Class for Behind-the-Counter Drugs
Seiten
2010
Nova Science Publishers Inc (Verlag)
978-1-60741-961-7 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-60741-961-7 (ISBN)
In the United States, most non-prescription drugs are available over-the-counter (OTC) in pharmacies and other stores. This book looks at the pharmacist, infrastructure, and cost-related issues which would have to be addressed before a BTC drug class could be established in the United States.
In the United States, most non-prescription drugs are available over-the-counter (OTC) in pharmacies and other stores. Experts have suggested that drug availability could be increased by establishing an additional class of non-prescription drugs that would be held behind the counter (BTC) but would require the intervention of a pharmacist before being dispensed; a similar class of drugs exists in many other countries. Although the Food and Drug Administration (FDA) has not developed a detailed proposal for a BTC drug class, it held a public meeting to explore the public health implications of BTC drug availability. This book explores the public health benefits of behind the counter availability of certain drugs without a prescription. In particular, the debate whether behind the counter may improve patient access to safe and effective drug products is discussed. This book looks at the pharmacist, infrastructure, and cost-related issues which would have to be addressed before a BTC drug class could be established in the United States.
In the United States, most non-prescription drugs are available over-the-counter (OTC) in pharmacies and other stores. Experts have suggested that drug availability could be increased by establishing an additional class of non-prescription drugs that would be held behind the counter (BTC) but would require the intervention of a pharmacist before being dispensed; a similar class of drugs exists in many other countries. Although the Food and Drug Administration (FDA) has not developed a detailed proposal for a BTC drug class, it held a public meeting to explore the public health implications of BTC drug availability. This book explores the public health benefits of behind the counter availability of certain drugs without a prescription. In particular, the debate whether behind the counter may improve patient access to safe and effective drug products is discussed. This book looks at the pharmacist, infrastructure, and cost-related issues which would have to be addressed before a BTC drug class could be established in the United States.
Preface; Non-prescription Drugs: Considerations Regarding a Behind-the-Counter Drug Class; Food & Drug Administration Behind the Counter Availability of Certain Drugs, Public Meeting; Index.
Erscheint lt. Verlag | 26.3.2010 |
---|---|
Zusatzinfo | Illustrations, unspecified |
Verlagsort | New York |
Sprache | englisch |
Maße | 230 x 155 mm |
Gewicht | 382 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
ISBN-10 | 1-60741-961-0 / 1607419610 |
ISBN-13 | 978-1-60741-961-7 / 9781607419617 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Arzneimittelverzeichnis für Deutschland (einschließlich …
Buch | Hardcover (2024)
Rote Liste Service GmbH (Verlag)
109,00 €